NuVasive Inc

$54.02 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About NuVasive Inc

NuVasive, Inc. is a developer of specialty spinal implants into a global medical technology company that is delivering integrated solutions for spine surgery. The Company's portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, and intraoperative neuromonitoring technology and service offerings. The Company's surgical access instruments include its Maxcess integrated split-blade retractor system. The Company's neuromonitoring software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support. The Company's Advanced Materials Science portfolio of specialized spinal implants is designed to advance spinal fusion by improving the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone (PEEK).

Stock Analysis

last close $54.02
1-mo return 8.6%
3-mo return 2.6%
avg daily vol. 513.66T
52-week high 64.43
52-week low 45.45
market cap. $2.8B
forward pe 22.3
annual div. -
roe -4.8%
ltg forecast 11.3%
dividend yield -
annual rev. $1.2B
inst own. -

Subscribe now for daily local and international financial news